Abstract: A first computer system identifies a failure case from a collected information, the collected information corresponds to one or more functions of a second system. The first computer system analyzes the failure case to determine a failure pattern. The first computer system determines whether the determined failure pattern corresponds to a stored failure pattern of a plurality of stored failure patterns in a database. In response to determining that the determined failure pattern corresponds to the stored failure pattern, the first computer system determines a remediation plan corresponding to the stored failure pattern, and utilizing the remediation plan to automatically remediate the failure case.

Abstract: A first computer system identifies a failure case from a collected information, the collected information corresponds to one or more functions of a second system. The first computer system analyzes the failure case to determine a failure pattern. The first computer system determines whether the determined failure pattern corresponds to a stored failure pattern of a plurality of stored failure patterns in a database. In response to determining that the determined failure pattern corresponds to the stored failure pattern, the first computer system determines a remediation plan corresponding to the stored failure pattern, and utilizing the remediation plan to automatically remediate the failure case.

Abstract: The present invention relates to a pharmaceutical delivery system comprising a gel-like structure that comprises at least one water-soluble polymer, such as, for example, povidone or hydroxypropyl cellulose, and at least one fatty acid, such as, for example, stearic acid or lauric acid. The invention further relates to a sustained release drug delivery composition comprising the gel-like structure and at least one drug trapped or dissolved therein, wherein said system is capable of releasing the drug in a dissolution medium at a controlled rate. The invention is also directed to a method for preparing the sustained release drug delivery composition.